NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

中國的Butylphthalide市場的相關調查報告書(2021年∼2025年)

Investigation Report on China's Butylphthalide Market 2021-2025

出版商 China Research and Intelligence 商品編碼 1008264
出版日期 內容資訊 英文 50 Pages
商品交期: 最快1-2個工作天內
價格
中國的Butylphthalide市場的相關調查報告書(2021年∼2025年) Investigation Report on China's Butylphthalide Market 2021-2025
出版日期: 2021年05月28日內容資訊: 英文 50 Pages
簡介

在中國市場的Butylphthalide的銷售量從2016年到2020年增加。尤其是,由於2019年的談判的降價後,年度成長率超越30%。其銷售量,從2018年的12億2,000萬人民幣到2019年的15億9,000萬人民幣最顯著增加。從2016年到2020年的中國市場中Butylphthalide的銷售量的年複合成長率為14.7%。

Butylphthalide的銷售量,預計隨著價格降低,從2021年到2025年有繼續增加的趨勢。Butylphthalide,2020年再次成為醫療保險的價格談判的對象藥物。談判成立後,預計價格下降50%左右,由於價格下降預計銷售量增加。

本報告提供中國的Butylphthalide市場的相關調查,市場規模和預測,趨勢,COVID-19的影響,價格,成長要素和機會,威脅,課題,市場佔有率等資訊。

目錄

第1章 Butylphthalide的相關概念

  • Butylphthalide的適應症
  • 中國的Butylphthalide的開發
  • 中國的Butylphthalide的政府核准
  • COVID-19對中國的Butylphthalide銷售的影響

第2章 中國的Butylphthalide銷售(2016-2020)

  • Butylphthalide的銷售量
    • 總銷售額
    • 各地區的銷售量
  • Butylphthalide的銷售量
    • 整體銷售量
    • 各地區銷售量
  • 中國的各劑型Butylphthalide銷售(2016-2020)
    • 注射
    • 軟體膠囊

第3章 中國的主要Butylphthalidemeka分析(2016-2020)

  • 主要Butylphthalidemeka的市場佔有率分析
    • 各銷售額市場佔有率調查
    • 各銷售量市場佔有率調查
  • CSPC Enbipu Pharmaceutical Co. Ltd.
    • 企業簡介
    • NBP(CSPC Enbipu Pharmaceutical Co. Ltd.的Butylphthalide)在中國的銷售
  • 其他公司分析

第4章 中國的各製造商Butylphthalide的價格(2020-2021)

  • CSPC Enbipu Pharmaceutical Co. Ltd.(NBP)
  • 其他公司分析

第5章 中國的Butylphthalide市場預測(2021-2025)

  • 中國的Butylphthalide市場開發的有影響力的要素
    • COVID-19對中國的Butylphthalide市場的影響
    • 市場成長要素和機會
    • 市場威脅與課題
  • 市場規模的預測
  • 市場趨勢的預測
目錄
Product Code: 2105499

Butylphthalide, developed by CSPC Enbipu Pharmaceutical Co. Ltd is used to treat mild to moderate acute ischemic stroke. Its soft capsule was approved in China in 2005, and its injection was approved in China in 2010. In 2009, Butylphthalide soft capsules were included in the Medicines List for National Basic Medical Insurance in China. In 2017, Butylphthalide injection was included in the Medicines List for National Basic Medical Insurance in China. By 2020, the only manufacturers are CSPC Enbipu Pharmaceutical Co. Ltd. in the Chinese Butylphthalide market.

According to CRI analysis, the sales of Butylphthalide have grown from 2016 to 2020. Especially, the annual growth rate is more than 30%, after the price cut through negotiations in 2019. Its sales have increased the most obviously, from CNY1.22 billion in 2018 to CNY 1.59 billion in 2019. The CAGR of the sales of Butylphthalide in the Chinese market from 2016 to 2020 is 14.7%.

CRI predicts that as the price of Butylphthalide will decrease, the sales volume of Butylphthalide will keep a rising trend from 2021 to 2025. Butylphthalide was once again listed as a drug for medical insurance price negotiations in 2020. It can be expected that the price will drop by about 50% after the negotiation is successful, which will lead to an increase in sales as the price drops. Moreover, Butylphthalide injections and patented capsules will expire in 2022 and 2023 respectively. After the patent expires, many companies will participate in the market competition. The price will drop with the addition of new manufacturers. The sales volume and sales will grow accordingly. Furthermore, with the increase of population aging, the incidence of some diseases continues to rise, prompting the demand for Butylphthalide in the Chinese market.

Topics Covered:

  • The impact of COVID-19 on China's Butylphthalide market
  • Sales value of China's Butylphthalide 2016-2020
  • Competitive landscape of China's Butylphthalide market
  • Prices of Butylphthalide in China
  • Prices of Butylphthalide in China by regions and manufacturers
  • Analysis of factors affecting the development of China's Butylphthalide market
  • Prospect of China's Butylphthalide market from 2021 to 2025

Table of Contents

1 Relevant Concepts of Butylphthalide

  • 1.1 Indications for Butylphthalide
  • 1.2 Development of Butylphthalide in China
  • 1.3 Governmental Approval of Butylphthalide in China
  • 1.4 The Impact of COVID-19 on Butylphthalide sales in China

2 Sales of Butylphthalide in China, 2016-2020

  • 2.1 Sales Value of Butylphthalide
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Regions
  • 2.2 Sales Volume of Butylphthalide
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Regions
  • 2.3 Sales of Butylphthalide by Dosage Form in China, 2016-2020
    • 2.3.1 Injection
    • 2.3.2 Soft Capsules

3 Analysis of Major Butylphthalide Manufacturers in China, 2016-2020

  • 3.1 Analysis of Market Share of Major Butylphthalide Manufacturers
    • 3.1.1 Investigation on Market Share by Sales Value
    • 3.1.2 Investigation on Market Share by Sales volume
  • 3.2 CSPC Enbipu Pharmaceutical Co. Ltd.
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of NBP (CSPC Enbipu Pharmaceutical Co. Ltd.'s Butylphthalide) in China
  • 3.3 Analysis of Other companies

4 Prices of Butylphthalide for Different Manufacturers in China, 2020-2021

  • 4.1 CSPC Enbipu Pharmaceutical Co. Ltd. (NBP)
  • 4.2 Analysis of Other companies

5 Prospect of Chinese Butylphthalide Market, 2021-2025

  • 5.1 Influential Factors of Chinese Butylphthalide Market Development
    • 5.1.1 The Impact of COVID-19 on Chinese Butylphthalide Market
    • 5.1.2 Market Drivers and Opportunities
    • 5.1.3 Market Threats and Challenges
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend

List of Charts

  • Chart Patent Information About Butylphthalide Injection Registration in China
  • Chart Patent Information About Butylphthalide Soft Capsules Registration in China
  • Chart Sales Value of Butylphthalide Injection over the World
  • Chart Sales Value of Butylphthalide Soft Capsules over the World
  • Chart Sales Value of Butylphthalide Injection in China, 2016-2020
  • Chart Sales Value of Butylphthalide Soft Capsules in China, 2016-2020
  • Chart Sales Value of Butylphthalide Injection in China by Regions, 2016-2020
  • Chart Sales Value of Butylphthalide Soft Capsules in China by Regions, 2016-2020
  • Chart Sales Volume of Butylphthalide Injection in China, 2016-2020
  • Chart Sales Volume of Butylphthalide Soft Capsules in China, 2016-2020
  • Chart Sales Volume of Butylphthalide Injection in China by Regions, 2016-2020
  • Chart Sales Volume of Butylphthalide Soft Capsules in China by Regions, 2016-2020
  • Chart Market Share by Sales Value of Top Butylphthalide Injection Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Butylphthalide Soft Capsules Manufacturers in China, 2016-2020
  • Chart Sales Value and Volume of NBP in China, 2016-2020
  • Chart Referential Prices of NBP in China by Regions, 2020-2021
  • Chart Forecast on Sales Value of Butylphthalide Injection in China, 2021-2025
  • Chart Forecast on Sales Value of Butylphthalide Soft Capsules in China, 2021-2025
  • Chart Forecast on Sales Volume of Butylphthalide Injection in China, 2021-2025
  • Chart Forecast on Sales Volume of Butylphthalide Soft Capsules in China, 2021-2025